Hovione reports on recent capacity expansion and future plans to support growth
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Pharmaceutical Technology Sourcing and Management, July 2006
The authors discuss the preparedness of European regulatory authorities to implement and enforce the recent EU Directives 2004/27 and 2004/28, which require that all medicines marketed in the EU be made with active pharmaceutical ingredients (APIs) that comply with the harmonized GMP standard ICH/Q7A.
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Hovione announced today that in the last year their manufacturing facilities were the object of eight inspections, performed by different Health Authorities.
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
The Sunday Times, February 18, 2018